Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Cancer Res. 2013 Apr 30;73(12):3591–3603. doi: 10.1158/0008-5472.CAN-12-4100

Figure 7. PD-1 and CTLA-4 pathway blockade reduces Treg-mediated suppression of CD8+ T cells in vitro and secretion of regulatory cytokines TGF-β and IL-10.

Figure 7

A) Representative expression of PD-1 and CTLA-4 by intra-tumoral and splenic Tregs in the same mouse. B) ICOS and folate receptor 4 (FR4) expression and MFI in PD-1hi and PD-1lo Tregs. C) TIL Tregs (± αPD-1) were co-cultured with CFSE-labeled CD8+ T cells and DCs (pretreated) in the presence of αCD3. Dividing cells were quantified after 4-days of culture by gating on the CFSElo population. D) [3H]-thymidine incorporation into effector T cells in the presence or absence of TIL Tregs. Tregs were either in direct contact with the effector cells or were separated by a transwell membrane. The whole tumor leucocytes were isolated and cultured ex vivo for 72 hours in the presence of AH-1 peptide and PD-1 and CTLA-4 blocking antibodies as indicated. After culture, supernatants were analyzed for secretion of TGF-β (E), IL-10 (F), and IFN-γ (G). Results are from 3 representative experiments. Bar graphs show mean ± SD.